Sharma Saniya, Basu Suprit, Goyal Taru, Sharma Madhubala, Barman Prabal, Kaur Gurjit, Shandilya Jitendra K, Vignesh Pandiarajan, Pilania Rakesh Kumar, Jindal Ankur Kumar, Dhaliwal Manpreet, Bhatia Prateek, Sreedharanunni Sreejesh, Rastogi Pulkit, Mallik Nabhajit, Sharma Prashant, Kaur Anupriya, Suri Deepti, Rawat Amit, Singh Surjit
Pediatric Allergy Immunology Unit, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Pediatric Hematology and Oncology, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
J Clin Immunol. 2025 Jun 19;45(1):108. doi: 10.1007/s10875-025-01895-x.
Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) is the commonest cause of familial hemophagocytic lymphohistiocytosis (FHLH). In this retrospective study, we analyzed 8 patients with a genetic diagnosis of FHL2 and then examined their clinicopathological and perforin flow cytometry results (< 10% expression). The atypical clinical features in our cohort included tuberculosis, lymphoreticular malignancy, and necrotizing enterocolitis in 3 patients. A disease-causing variant was identified in the PRF1 gene in all eight patients, comprising missense (n = 6), null (n = 1), and in-frame deletion (n = 1). Five patients had homozygous exon 3 disease-causing variants, two had homozygous exon 2 disease-causing variants, and one had compound heterozygous disease-causing variants in exon 2 and exon 3. After an extensive literature search, the mutations present in our North Indian cohort, including c.1284G > A, c.895C > T, c.853_855del, c.203G > A, and c.757G > A, are reported for the first time from India. Clinical and immunological phenotypes of c.1284G > A and c.203G > A variants have not been published in the literature. Hemophagocytosis was evident in bone marrow in 6 cases. Hyperferritinemia was absent in 3 cases, including c.148G > A, c. 895C > T, and c.1349C > T homozygous variants. Neurological involvement, lymphoreticular malignancy, and necrotizing enterocolitis were seen in 2, 1, and 1 cases, respectively. Infections were present in 4 cases. Five children succumbed to HLH, and three are alive and planned for a hematopoietic stem cell transplant. FHL2 should be suspected in children with HLH irrespective of the age of onset, atypical clinical phenotype, family history, ferritin and fibrinogen levels, and infections. Flow cytometry-based perforin assay helps in rapid diagnosis of FHL2.
2型家族性噬血细胞性淋巴组织细胞增生症(FHL2)是家族性噬血细胞性淋巴组织细胞增生症(FHLH)最常见的病因。在这项回顾性研究中,我们分析了8例经基因诊断为FHL2的患者,然后检查了他们的临床病理和穿孔素流式细胞术结果(表达<10%)。我们队列中的非典型临床特征包括3例患者出现结核病、淋巴网状恶性肿瘤和坏死性小肠结肠炎。在所有8例患者的PRF1基因中均鉴定出致病变异,包括错义变异(n = 6)、无效变异(n = 1)和框内缺失变异(n = 1)。5例患者有纯合子外显子3致病变异,2例有纯合子外显子2致病变异,1例在外显子2和外显子3中有复合杂合子致病变异。经过广泛的文献检索,我们印度北部队列中存在的突变,包括c.1284G>A、c.895C>T、c.853_855del、c.203G>A和c.757G>A,是首次从印度报道。c.1284G>A和c.203G>A变异的临床和免疫表型尚未在文献中发表。6例患者骨髓中可见噬血细胞现象。3例患者无高铁蛋白血症,包括c.148G>A、c.895C>T和c.1349C>T纯合子变异。分别有2例、1例和1例患者出现神经受累、淋巴网状恶性肿瘤和坏死性小肠结肠炎。4例患者存在感染。5名儿童死于HLH,3名存活并计划进行造血干细胞移植。无论发病年龄、非典型临床表型、家族史、铁蛋白和纤维蛋白原水平以及感染情况如何,HLH患儿均应怀疑患有FHL2。基于流式细胞术的穿孔素检测有助于FHL2的快速诊断。